Yahoo Web Search

Search results

1. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 2 days ago

     LA JOLLA, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that

2. • Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...

     Morningstar· 6 days ago

     OPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...

3. • 

     Study: Surgical Intervention Improves Quality of L | Newswise

     Newswise· 7 days ago

     The results, published in the May 21, 2024 online edition of Otology & Neurotology, showed that...

4. • Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...

     Morningstar· 6 days ago

     FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic ...

5. • Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...

     Morningstar· 7 days ago

     Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a

6. • Adena Power Selected for Army SBIR Phase 1 Award

     Digital Journal· 5 days ago

     Jasvant Modi Funds Groundbreaking PhD Scholarship in Jain Studies at SOAS University of London More from Digital Journal Let’s waltz! Vienna ball season back in full swing ...

7. • Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...

     FOX 23 News Albany· 6 days ago

     Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American Society of Clinical ...